Evidence map›Paper›PMID 25533962›Full record

ArticleNature2015

Large-scale discovery of novel genetic causes of developmental disorders.

Deciphering Developmental Disorders Study

Open access · bronzeAbstract read
In one paragraph

Article in Nature, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 656 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
656citing papers in PubMed, 5 pooled it
72.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

656 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,185 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. An updated catalog ofFrontiers in molecular neuroscience · 2023
    Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Patient Perspectives on Psychiatric Polygenic Risk Scores in Reproductive Decision-Making and Polygenic Embryo Screening.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. bioRxiv : the preprint server for biology · 2026
    Article
  19. Translational pediatrics · 2026
    Article
  20. Shared and distinct phenotypic profiles among neurodevelopmental disorder genes.medRxiv : the preprint server for health sciences · 2026
    Article

596 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Deciphering Developmental Disorders Study

Funding

Cancer Research UK 15934Chief Scientist Office CZD/16/6Department of HealthMedical Research Council MC_PC_U127561093Wellcome Trust 091986Wellcome Trust 098395Wellcome Trust 100140Wellcome Trust WT098051
6 · The paper itself

Abstract

Despite three decades of successful, predominantly phenotype-driven discovery of the genetic causes of monogenic disorders, up to half of children with severe developmental disorders of probable genetic origin remain without a genetic diagnosis. Particularly challenging are those disorders rare enough to have eluded recognition as a discrete clinical entity, those with highly variable clinical manifestations, and those that are difficult to distinguish from other, very similar, disorders. Here we demonstrate the power of using an unbiased genotype-driven approach to identify subsets of patients with similar disorders. By studying 1,133 children with severe, undiagnosed developmental disorders, and their parents, using a combination of exome sequencing and array-based detection of chromosomal rearrangements, we discovered 12 novel genes associated with developmental disorders. These newly implicated genes increase by 10% (from 28% to 31%) the proportion of children that could be diagnosed. Clustering of missense mutations in six of these newly implicated genes suggests that normal development is being perturbed by an activating or dominant-negative mechanism. Our findings demonstrate the value of adopting a comprehensive strategy, both genome-wide and nationwide, to elucidate the underlying causes of rare genetic disorders.

Indexed as

AdolescentAnimalsCarrier ProteinsCell Cycle ProteinsChildChild, PreschoolChromosomal Proteins, Non-HistoneChromosome AberrationsDEAD-box RNA HelicasesDevelopmental DisabilitiesDNA-Binding ProteinsDynamin IExomeFemaleGene Expression Regulation, DevelopmentalGenes, DominantADNP protein, humanBCL11A protein, humanCarrier ProteinsCell Cycle ProteinsCERT1 protein, humanCHAMP1 protein, humanChromosomal Proteins, Non-HistoneDDX3X protein, humanDEAD-box RNA HelicasesDNA-Binding ProteinsDynamin IGuanine Nucleotide Exchange FactorsHomeodomain ProteinsNerve Tissue ProteinsNuclear ProteinsPCGF2 protein, humanPhosphoproteinsPOGZ protein, humanPolycomb Repressive Complex 1PPP2R1A protein, humanPPP2R5D protein, humanProtein Phosphatase 2Protein Serine-Threonine KinasesPURA protein, humanRepressor ProteinsTranscription FactorsTransposasesTRIO protein, human

Identifiers

PMID25533962
PMCPMC5955210
OpenAlexW2087216143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.